Chison Medical Technologies Stock Annual Yield
| 688358 Stock | 26.51 0.24 0.91% |
Chison Medical Technologies fundamentals help investors to digest information that contributes to Chison Medical's financial success or failures. It also enables traders to predict the movement of Chison Stock. The fundamental analysis module provides a way to measure Chison Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chison Medical stock.
Chison | Annual Yield |
Chison Medical Technologies Company Annual Yield Analysis
Chison Medical's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Chison Medical Technologies has an Annual Yield of 0.0%. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).
Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Chison Fundamentals
| Current Valuation | 1.91 B | ||||
| Price To Book | 2.16 X | ||||
| Price To Sales | 6.55 X | ||||
| Revenue | 483.84 M | ||||
| EBITDA | 125.83 M | ||||
| Net Income | 146.48 M | ||||
| Total Debt | 4.02 M | ||||
| Cash Flow From Operations | 85.91 M | ||||
| Market Capitalization | 3.55 B | ||||
| Total Asset | 1.52 B | ||||
| Retained Earnings | 305.98 M | ||||
| Working Capital | 1.2 B | ||||
| Net Asset | 1.52 B |
About Chison Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chison Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chison Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chison Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Chison Stock
Chison Medical financial ratios help investors to determine whether Chison Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chison with respect to the benefits of owning Chison Medical security.